Furthermore, KRAS and HIF1A-As2 were highly expressed in the lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) compared to the normal lung from TCGA datasets (Fig. 1G, Supplementary Fig 1H), elevated in late-stage compared to early-stage tumors from a second independent cohort of Biomax LUAD paired TMA samples (Fig. 1I, J; Supplementary Fig 1J). The gene discussed is KRAS; the disease is lung adenocarcinoma.